Insight 20223
August 31 – September 3 in Berlin
Resident Physician / Psychotherapist

Moritz Spangemacher, M.D.

Department of Molecular Neuroimaging, Central Institute of Mental Health, Mannheim

Moritz Spangemacher is a resident physician at the Central Institute of Mental Health in Mannheim. He works in the department of Molecular Neuroimaging, led by Prof. Gerhard Gründer. His focus lies in the treatment of treatment-resistant depression and the research on psychotropic drugs. He works as a therapist in the EPisoDE study, which is a Phase-II-study that investigates the safety and efficacy of psilocybin in treatment-resistant depression. He is also partly responsible for the fMRI part of the study that explores the underlying mechanisms of the psilocybin effect. Furthermore, he investigates potential blood biomarkers for treatment response in the course of ketamine treatment. He completed his medical studies at Ludwig Maximilians University (LMU) in Munich and previously studied philosophy at Saarland University.

Go to Top